Grunde Gjesdal
1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Impact of post-transplant diabetes on left ventricular function following heart transplantation
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device : Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA)
(
- Contribution to journal › Article
-
Mark
Cardiovascular implantable electronic device therapy in patients with left ventricular assist devices : insights from TRAViATA
(
- Contribution to journal › Article
-
Mark
Vårdprogram hjärttransplantation
2021)(
- Book/Report › Report
- 2020
-
Mark
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial
(
- Contribution to journal › Article
-
Mark
Iron Deficiency in Left Ventricular Assist Device Recipients
2020) In The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 39(4 SUPPL). p.157-158(
- Contribution to journal › Published meeting abstract
-
Mark
Patient Outcomes after Heart Transplantation in Sweden between 1988 and 2017 : Continuous Improvement in Survival
2020) In The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 39(4). p.284-284(
- Contribution to journal › Published meeting abstract
-
Mark
ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)
(
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
Implantation Strategies and Outcomes of Patients Treated with Left Ventricular Assist Devices Awaiting for Heart Transplant in Europe and United States: Data from the TransAtlantic Registry on VAD and Transplant (TRAVIATA)
(
- Contribution to journal › Published meeting abstract
-
Mark
Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock
(
- Contribution to journal › Article